Antibody-dependent enhancement of viral infectivity.
D000818:Animals; D000914:Antibodies, Viral / Q000276:immunology*; D000918:Antibody Specificity; D002460:Cell Line; D003716:Dengue Virus / Q000276:immunology; D000939:Epitopes / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D008262:Macrophage Activation; D008264:Macrophages / Q000276:immunology; D011951:Receptors, Complement / Q000276:immunology; D011961:Receptors, Fc / Q000276:immunology; D013045:Species Specificity; D014765:Viral Vaccines / Q000276:immunology; D014777:Virus Diseases / Q000276:immunology / Q000382:microbiology; D018406:Virus Physiological Phenomena; D014779:Virus Replication; D014780:Viruses / Q000276:immunology
D000914:Antibodies, Viral; D000939:Epitopes; D007074:Immunoglobulin G; D011951:Receptors, Complement; D011961:Receptors, Fc; D014765:Viral Vaccines